Please login to the form below
anal cancer
This page shows the latest anal cancer news and features for those working in and with pharma, biotech and healthcare.
Gardasil cleared for anal cancer prevention in EU
It is also approved to prevent genital warts. Specifically, the EC has cleared Gardasil to prevent anal cancer and anal precancerous lesions – or anal intraepithelial neoplasia (AIN) - caused by HPV, recognising ... Cervarix has also been shown in
Latest news
-
New FDA approval for Merck's Gardasil
Merck's HPV vaccine, Gardasil, has received approval from the US Food and Drug Administration for the prevention of anal cancer due to HPV. ... A panel of FDA advisors had previously recommended the agency approve Gardasil for the indication of
-
FDA advisors support anal cancer vaccine
Outside advisors to the US Food and Drug Administration have recommended the approval of Merck's Gardasil in preventing anal cancer. ... preventing anal cancer, which is caused by human papillomavirus (HPV) in approximately 90 per cent of cases. .
-
Gardasil effective against anal cancer
Merck's Gardasil has shown to be effective in preventing HPV-related anal cancer, according to results from a phase III trial. ... No cases of anal cancer were seen in either the placebo or vaccine group.
More from news
Approximately 1 fully matching, plus 3 partially matching documents found.
Latest Intelligence
-
Immunisation politicised
Practitioners were concerned that a hasty introduction of the vaccine would lead to lower participation rates in cervical cancer screening programmes using the pap smear test. ... For example, the remarkable silence around the fact that some strains of
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Gilead agrees $21bn buyout of Immunomedics
- Regeneron launches phase 3 COVID-19 antibody trial in the UK
- BioNTech bolsters COVID-19 vaccine capacity with Novartis deal
- Roche’s Ocrevus boasts positive long-term data in MS
- Gavi says 76 wealthy countries have committed to COVAX vaccine facility
- Leadership change within Bedrock Group
- InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
- Envision Pharma Group scoops two Silvers at the PM Society Digital Awards 2020
- Alone we can do so little, together we can do so much
- What can't we afford to treat anymore?
- OPEN VIE is awarded a Bronze Award at the PM Society Digital Awards 2020
- BioNTech bolsters COVID-19 vaccine capacity with Novartis deal
PMHub
Valid Insight
Valid Insight is an award-winning pharmaceutical global market access consultancy....
Latest intelligence
- InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
- Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
- Alone we can do so little, together we can do so much
- Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
- 7 important considerations for creating an inclusive clinical trial website
- You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...
Quick links
Infographics
